skip to Main Content

29 August 2020

On the go? Here’s the Friday recap.

On Day 2 of Digital ILC 2020, the Daily News brings you highlights from General Session II and EASL’s…

28 August 2020

EASL recognizes outstanding contributions to hepatology

In today’s award ceremony, EASL acknowledged outstanding researchers for their major scientific contributions and paid tribute to Professor…

28 August 2020

A giant in hepatology: a tribute to Prof. Roger Williams (29 August 1931 –26 July 2020)

At Digital ILC 2020, EASL planned to give a Recognition Award to Prof. Roger Williams to honour his…

28 August 2020

Hepatitis C: The journey toward elimination

In today’s focused session on HCV elimination, clinicians, scientists and programme managers from around the world convened to…

28 August 2020

Novel immunotherapies demonstrate potential in advanced hepatocellular carcinoma

Today’s oncology session highlighted the potential of new immunotherapies for treating patients with unresectable HCC. Patients with advanced…

28 August 2020

What’s in the pipeline for hepatitis B and D treatment?

Progress towards the development of curative treatments for hepatitis B and HBV/HDV coinfection were showcased at Digital ILC…

Share